48,460
edits
Difference between revisions of "Ancillary testing in prostate cancer"
Jump to navigation
Jump to search
Ancillary testing in prostate cancer (view source)
Revision as of 15:10, 1 November 2022
, 15:10, 1 November 2022→PARP inhibitors
| Line 5: | Line 5: | ||
Molecular panel: | Molecular panel: | ||
*BRCA1 | *[[BRCA1]]. | ||
*BRCA2 | *[[BRCA2]]. | ||
*ATM | *ATM. | ||
*PALB2 | *PALB2. | ||
==See also== | ==See also== | ||